Spampinato, S.; Venanzi Rullo, E.; Conti, G.N.; De Vito, A.; Marino, A.; Cirelli, T.; Coco, V.; Mirabile, A.; Fontana del Vecchio, R.; Franco, A.;
et al. CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation. Pathogens 2025, 14, 633.
https://doi.org/10.3390/pathogens14070633
AMA Style
Spampinato S, Venanzi Rullo E, Conti GN, De Vito A, Marino A, Cirelli T, Coco V, Mirabile A, Fontana del Vecchio R, Franco A,
et al. CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation. Pathogens. 2025; 14(7):633.
https://doi.org/10.3390/pathogens14070633
Chicago/Turabian Style
Spampinato, Serena, Emmanuele Venanzi Rullo, Giuseppe Nicolò Conti, Andrea De Vito, Andrea Marino, Teresa Cirelli, Viviana Coco, Alessia Mirabile, Rossella Fontana del Vecchio, Antonina Franco,
and et al. 2025. "CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation" Pathogens 14, no. 7: 633.
https://doi.org/10.3390/pathogens14070633
APA Style
Spampinato, S., Venanzi Rullo, E., Conti, G. N., De Vito, A., Marino, A., Cirelli, T., Coco, V., Mirabile, A., Fontana del Vecchio, R., Franco, A., Montineri, A., Frasca, C., Gullotta, C., Paternò Raddusa, M. S., Russotto, Y., Fugooah, A., Pulvirenti, S., Sofia, S., Pantò, G.,
... Nunnari, G.
(2025). CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation. Pathogens, 14(7), 633.
https://doi.org/10.3390/pathogens14070633
